RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Rein Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.55−0.04 (-6.49%)
Close on Oct 19, 2026
- Market cap
- $37.03M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SEC filings
40 of Rein Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 4, 2026 | Sep 4, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 21, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 20, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | May 4, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 16, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2026 | Jan 16, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2025 | May 12, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2025 | Apr 22, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2025 | Apr 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2024 | Aug 21, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 26, 2024 | Jul 26, 2024 | SEC EDGAR |